PrecisCa
Avatar

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Analysis: Increasing the Use of Aromatase Inhibitors in a Subset of Premenopausal Women

By PrecisCa FEATURING Mark Pegram
By PrecisCa FEATURING Mark Pegram
894 views
August 18, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Recommended

12:14

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.1K views

·

5 months ago
10:53

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

Kirollos Hanna

2.1K views

·

4 months ago
11:31

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, TROPI…

Insights from 2023 ASCO® Annual Meeting

P. Tarantino

8.2K views

·

1 year ago
17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.5K views

·

2 months ago
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views

·

9 months ago
17:39

2023 Menopause Update

Yale School of Medicine

M. Minkin

9.0K views

·

1 year ago
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

720 views

·

1 month ago
08:49

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

735 views

·

1 month ago
17:20

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNOTE-75…

Insights from 2023 ESMO Annual Meeting

P. Tarantino

2.1K views

·

1 year ago
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views

·

1 year ago
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

919 views

·

4 months ago
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

930 views

·

5 months ago
38:49

ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

514 views

·

1 month ago
21:31

ESMO Breast 2024 Summary: "Community Oncologists Highlights"

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney, H. Rugo

1.1K views

·

5 months ago
20:32

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Bre…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

520 views

·

1 month ago
12:07

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

546 views

·

2 months ago
21:34

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

642 views

·

1 month ago
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

464 views

·

1 month ago
09:26

DESTINY-Breast06 - T-DXd vs. Physician’s Choice of Chemotherapy in H…

2024 ASCO® Annual Meeting Insights Hub

G. Curigliano

706 views

·

5 months ago
15:19

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

946 views

·

4 months ago
AUTOPLAY